Loading chat...

MN HF2637

Bill

Status

Introduced

3/20/2019

Primary Sponsor

Alice Mann

Click for details

Origin

House of Representatives

91st Legislature 2019-2020

AI Summary

  • Amends Minnesota Statutes 2018, section 62J.23, subdivision 2, to clarify that "prescription drug" includes prescription drugs administered through infusion, along with related services and supplies.

  • Allows individuals to receive discounts, price reductions, or limited-time free supplies of prescription drugs (including infusion drugs), medical supplies, or medical equipment from manufacturers, health plan companies, or pharmacy benefit managers, subject to specified conditions.

  • Permits pharmaceutical manufacturers and device manufacturers to provide ancillary products necessary for treatment at discounted, reduced, or no cost, and to provide trinkets or mementos of insignificant value to patients.

  • Maintains prohibition on benefits, rewards, remuneration, or incentives for continued product use, with exceptions for activities permitted under existing discount provisions and ancillary product assistance.

  • Does not prohibit health plan companies from offering tiered formularies with different co-payment or cost-sharing amounts for different drugs.

Legislative Description

Provider conflict of interest restrictions for infusion drugs exemption provided.

Last Action

Introduction and first reading, referred to Commerce

3/20/2019

Committee Referrals

Commerce3/20/2019

Full Bill Text

No bill text available